NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection
Authors:
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infectionTherapies, 2020
- Severe COVID-19 infection associated with endothelial activationThrombosis Research, 2020
- ADAM17 inhibition may exert a protective effect on COVID-19Nephrology Dialysis Transplantation, 2020
- Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health IssueCureus, 2017
- NSAIDs: Learning new tricks from old drugsEuropean Journal of Immunology, 2014
- Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolismJournal of Thrombosis and Haemostasis, 2011
- Angiotensin II–Mediated Microvascular ThrombosisHypertension, 2010
- Nonsteroidal Anti-Inflammatory Drugs and the KidneyPharmaceuticals, 2010
- COX‐1, and not COX‐2 activity, regulates airway function: relevance to aspirin‐sensitive asthmaThe FASEB Journal, 2008
- Bioactive angiotensin peptides: focus on angiotensin IVJournal of the Renin-Angiotensin-Aldosterone System, 2001